Where does Tandem Diabetes Care, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Tandem Diabetes Care, Inc. ranks #2,352 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Tandem Diabetes Care, Inc. hold?

Tandem Diabetes Care, Inc. holds 167 US utility patents granted between 2015 and 2025, spanning 26 technology areas.

What is Tandem Diabetes Care, Inc.'s Innovation Score?

Tandem Diabetes Care, Inc. has an Innovation Score of 53.6 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Tandem Diabetes Care, Inc.'s patent grant rate increasing or decreasing?

Tandem Diabetes Care, Inc.'s recent grant velocity is +41% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Tandem Diabetes Care, Inc.'s patents?

Tandem Diabetes Care, Inc.'s patents average 18.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Tandem Diabetes Care, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Tandem Diabetes Care, Inc.

Q: What technology areas does Tandem Diabetes Care, Inc. focus on?

Tandem Diabetes Care, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 141 patents, ranking #55 of 3,490 assignees active in that subclass. Grants appear in 26 CPC subclasses total.

USPTO PatentsView assignee record - 167 granted patents across 26 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Tandem ranks #2,352 of 49,997 tracked US assignees by granted-patent volume, with 167 patents across 26 technology areas.

#2,352
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.6/100): 18.0
avg claims per patent: +41%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2352 · US Corporation #2,352 · 167 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 167 grants
TOP-DECILE #2,352/49,997
PHOTO-FINISH Materion
CPC-FOCUS A61M · 26 areas
INNOV-PAR 53.6/100
CLAIMS-RICH 18.0 claims/avg
TYPE-USCORP US Corporation
VEL-UP +41% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Materion Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tandem’s 53.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 17.7 pts (33%) Velocity 7.1 pts (13%) Breadth 18.0 pts (34%) Claim depth 10.8 pts (20%)

Qualcomm Incorporated · highest

85
Heatcraft Refrigerat… · near

54
Eppendorf · near

54
Horiba Stec · near

54
Tandem Diabetes Care · this assignee

54
Sanden · near

54
3D Lighting… · lowest

7

What this shows Tandem's Innovation Score is 53.6/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Tandem?

Each dot is one of Tandem’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tandem’s own 18.0 claims/patent is ABOVE the 15.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Tandem vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tandem's grants concentrate

Tandem Diabetes Care, Inc. is a focused PatentsView assignee: 26 CPC subclasses with 84.4% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2024 (22 grants) versus a trough of 9 in 2015. By volume, Tandem sits between Materion Corporation and Canva Pty Ltd.

Tandem's three-year grant acceleration

From 2019–2021 to 2022–2024, Tandem Diabetes Care, Inc. moved from 51 to 54 grants (1.06x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,046. See the growth leaderboard.

Materion

167
Rakuten Mobile

167
Societe BIC

167
Software

167
The Board of Trus…

167
The University of…

167
Vivotek

167
Tandem Diabetes C… ◀

167
Canva Pty

166

What this shows Tandem holds 167 patents at rank #2,352, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Tandem

By rank, the assignees closest to #2,352 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Tandem's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Tandem, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Tandem ranks #55 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (54 here).

Horiba Stec, Co., Ltd. 54 Eppendorf AG 54 Sanden Corporation 54 Heatcraft Refrigeration Products LLC 54

Similar claim depth

Nearest assignees by average claims per patent (18.0 here).

Holtec International 18.0 avg Bank of America Corporation 18.0 avg CareFusion Germany 326 GmbH 18.0 avg Storagecraft Technology Corporation 18.0 avg

Tandem's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Tandem Diabetes Care, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	5.4%
2016	12	7.2%
2017	10	6.0%
2018	11	6.6%
2019	19	11.4%
2020	17	10.2%
2021	15	9.0%
2022	18	10.8%
2023	14	8.4%
2024	22	13.2%
2025partial year	20	12.0%

Which technologies does Tandem Diabetes Care, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 141

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 91

G06F - Electric Digital Data Processing 23

A61B - DIAGNOSIS; SURGERY; Identification 15

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 10

H04W - Wireless Communication Networks 10

F16J - Pistons ; CYLINDERS; Sealings 7

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

G06N - Computing Arrangements Based ON Specific Computational Models 7

Y02D - Climate Change Mitigation Technologies IN Information AND Communication Technologies [ICT], I.E. Information AND Communication Technologies Aiming AT THE Reduction OF Their OWN Energy USE 6

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 5

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 5

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 5

G09G - Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information 5

Top 15 of 26 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Tandem Diabetes Care, Inc.'s patent record in context - here's where to go next.

Tandem Diabetes Care, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 84.4% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #2,352 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Tandem Diabetes Care, Inc. against Materion Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.